Company: FLDDW
Filing Date: 2025-01-14
Form Type: S-4/A
Source: 0001213900-25-003167
Chunk: 48

Company: Fold Holdings, Inc.
Filing Date: 2025-01-14
Form: S-4/A
Chunk 48
---
 financial advisors to engage in, any special selling efforts or stabilization or price support activities in connection with New Fold Common Stock that will be outstanding immediately following the Closing Date. All of these differences from an underwritten public offering of Fold’s securities could result in a more volatile price for New Fold Common Stock following the Closing Date. Further, we will not conduct a traditional “roadshow” with underwriters prior to the opening of initial post -closingtrading of New Fold Common Stock on Nasdaq. There can be no guarantee that any information made available in this proxy statement/prospectus and/or otherwise disclosed or filed with the SEC will have the same impact on investor education as a traditional “roadshow” conducted in connection with an 18 underwritten initial public offering. As a result, there may not be efficient or sufficient price discovery with respect to New Fold Common Stock or sufficient demand among potential investors immediately after the Closing Date, which could result in a more volatile price for New Fold Common Stock. In addition, our initial stockholders, including our Sponsor, have interests in the Business Combination that are different from or are in addition to our stockholders and that would not be present in an underwritten public offering of Fold’s securities. Such interests may have influenced our Board in making its recommendation that you vote in favor of the approval of the Business Combination Proposal and the other proposals described in this proxy statement/prospectus. These actual or potential conflicts of interest are, to the extent material, described in the section entitled “ The Business Combination — Interests of Emerald’s Directors and Officers in the Business Combination” and “ The Business Combination — Interests of Fold’s Directors and Executive Officers in the Business Combination” beginning on page 138 of this proxy statement/prospectus. Accordingly, as an investor in the Business Combination, you may be exposed to increased risk when compared to investing in a traditional underwritten initial public offering. Q.What do I need to do now? A.You are urged to carefully read and consider the information contained in this proxy statement/prospectus, including the financial statements and annexes attached hereto, and to consider how the Business Combination will affect you as a stockholder. You should then vote as soon as possible in accordance with the instructions provided in this proxy statement/prospectus on the enclosed proxy card or, if you hold your shares through a brokerage firm, bank or other nominee, on the voting instruction form provided by the broker, bank or nominee. Q.When and where is the special meeting? A.The special meeting will take place on